Credit Suisse’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $792K | Buy |
102,710
+766
| +0.8% | +$5.91K | ﹤0.01% | 2398 |
|
2023
Q4 | $916K | Buy |
101,944
+40,316
| +65% | +$362K | ﹤0.01% | 2379 |
|
2023
Q3 | $551K | Sell |
61,628
-25,049
| -29% | -$224K | ﹤0.01% | 2620 |
|
2023
Q2 | $1.33M | Buy |
86,677
+33,015
| +62% | +$507K | ﹤0.01% | 2179 |
|
2023
Q1 | $1.21M | Buy |
53,662
+8,351
| +18% | +$188K | ﹤0.01% | 2196 |
|
2022
Q4 | $953K | Sell |
45,311
-1,444
| -3% | -$30.4K | ﹤0.01% | 2359 |
|
2022
Q3 | $1.15M | Buy |
46,755
+4,574
| +11% | +$113K | ﹤0.01% | 2210 |
|
2022
Q2 | $1.02M | Sell |
42,181
-2,973
| -7% | -$72K | ﹤0.01% | 2346 |
|
2022
Q1 | $1.16M | Sell |
45,154
-970
| -2% | -$25K | ﹤0.01% | 2435 |
|
2021
Q4 | $1.43M | Buy |
46,124
+6,172
| +15% | +$192K | ﹤0.01% | 2352 |
|
2021
Q3 | $970K | Buy |
39,952
+6,877
| +21% | +$167K | ﹤0.01% | 2607 |
|
2021
Q2 | $482K | Sell |
33,075
-2,518
| -7% | -$36.7K | ﹤0.01% | 3045 |
|
2021
Q1 | $889K | Sell |
35,593
-25,316
| -42% | -$632K | ﹤0.01% | 2646 |
|
2020
Q4 | $1.66M | Buy |
60,909
+7,748
| +15% | +$211K | ﹤0.01% | 2243 |
|
2020
Q3 | $982K | Sell |
53,161
-13,102
| -20% | -$242K | ﹤0.01% | 2282 |
|
2020
Q2 | $1.35M | Buy |
66,263
+30,449
| +85% | +$621K | ﹤0.01% | 2133 |
|
2020
Q1 | $523K | Sell |
35,814
-5,972
| -14% | -$87.2K | ﹤0.01% | 2497 |
|
2019
Q4 | $593K | Buy |
41,786
+7,374
| +21% | +$105K | ﹤0.01% | 2816 |
|
2019
Q3 | $399K | Buy |
34,412
+9,514
| +38% | +$110K | ﹤0.01% | 2916 |
|
2019
Q2 | $500K | Sell |
24,898
-9,096
| -27% | -$183K | ﹤0.01% | 2790 |
|
2019
Q1 | $769K | Buy |
33,994
+2,076
| +7% | +$47K | ﹤0.01% | 2543 |
|
2018
Q4 | $723K | Sell |
31,918
-29,378
| -48% | -$665K | ﹤0.01% | 2538 |
|
2018
Q3 | $1.76M | Buy |
61,296
+16,871
| +38% | +$484K | ﹤0.01% | 2034 |
|
2018
Q2 | $1.21M | Sell |
44,425
-17,142
| -28% | -$468K | ﹤0.01% | 2456 |
|
2018
Q1 | $1.38M | Buy |
61,567
+14,676
| +31% | +$328K | ﹤0.01% | 2354 |
|
2017
Q4 | $989K | Sell |
46,891
-8,360
| -15% | -$176K | ﹤0.01% | 2543 |
|
2017
Q3 | $1.38M | Buy |
55,251
+22,989
| +71% | +$572K | ﹤0.01% | 2433 |
|
2017
Q2 | $624K | Sell |
32,262
-24,763
| -43% | -$479K | ﹤0.01% | 2635 |
|
2017
Q1 | $1.05M | Buy |
57,025
+4,407
| +8% | +$81.3K | ﹤0.01% | 2482 |
|
2016
Q4 | $996K | Buy |
52,618
+2,971
| +6% | +$56.2K | ﹤0.01% | 2698 |
|
2016
Q3 | $1.11M | Sell |
49,647
-20,453
| -29% | -$458K | ﹤0.01% | 2548 |
|
2016
Q2 | $1.25M | Buy |
70,100
+15,032
| +27% | +$268K | ﹤0.01% | 2469 |
|
2016
Q1 | $752K | Buy |
55,068
+1,417
| +3% | +$19.4K | ﹤0.01% | 2661 |
|
2015
Q4 | $1.04M | Buy |
53,651
+21,323
| +66% | +$411K | ﹤0.01% | 2586 |
|
2015
Q3 | $656K | Sell |
32,328
-38,537
| -54% | -$782K | ﹤0.01% | 2996 |
|
2015
Q2 | $2.35M | Buy |
70,865
+1,456
| +2% | +$48.3K | ﹤0.01% | 2210 |
|
2015
Q1 | $1.66M | Buy |
69,409
+38,326
| +123% | +$918K | ﹤0.01% | 2310 |
|
2014
Q4 | $381K | Buy |
31,083
+4,061
| +15% | +$49.8K | ﹤0.01% | 3539 |
|
2014
Q3 | $244K | Buy |
27,022
+10,390
| +62% | +$93.8K | ﹤0.01% | 3645 |
|
2014
Q2 | $195K | Sell |
16,632
-40,825
| -71% | -$479K | ﹤0.01% | 3953 |
|
2014
Q1 | $1.22M | Buy |
+57,457
| New | +$1.22M | ﹤0.01% | 2629 |
|